W John Edmunds

Summary

Affiliation: Central Public Health Laboratory
Country: UK

Publications

  1. ncbi request reprint The 23-valent pneumococcal polysaccharide vaccine. Part II. A cost-effectiveness analysis for invasive disease in the elderly in England and Wales
    Alessia Melegaro
    Modelling and Economics Unit, Health Protection Agency, Communicable Disease Surveillance Centre, London NW9 5EQ, UK
    Eur J Epidemiol 19:365-75. 2004
  2. doi request reprint Estimating the impact of childhood influenza vaccination programmes in England and Wales
    Emilia Vynnycky
    Modelling and Economics Unit, Health Protection Agency Centre for Infections, 61 Colindale Avenue, Colindale, London NW9 5HT, UK
    Vaccine 26:5321-30. 2008
  3. pmc The average cost of measles cases and adverse events following vaccination in industrialised countries
    HELENE CARABIN
    Department of Infectious Disease Epidemiology, Imperial College Faculty of Medicine, London, UK
    BMC Public Health 2:22. 2002
  4. ncbi request reprint The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales
    W J Edmunds
    Department of Economics, City University, Northampton Square, EC1 0HB, London, UK
    Vaccine 19:3076-90. 2001
  5. ncbi request reprint The effect of vaccination on the epidemiology of varicella zoster virus
    W J Edmunds
    Immunisation Division, Colindale, London NW9 5EQ, UK
    J Infect 44:211-9. 2002
  6. ncbi request reprint The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales
    W John Edmunds
    Immunisation Division, PHLS Communicable Disease Surveillance Centre, 61 Collindale Avenue, NW9 5EQ, London, UK
    Vaccine 20:1316-30. 2002
  7. ncbi request reprint Measles vaccination in Africa: by how much could routine coverage be improved?
    W J Edmunds
    PHLS Communicable Disease Surveillance Centre, NW9 5EQ, London, UK
    Vaccine 20:16-8. 2001
  8. ncbi request reprint Modeling future changes to the meningococcal serogroup C conjugate (MCC) vaccine program in England and Wales
    Caroline L Trotter
    Immunisation Department, Health Protection Agency Centre for Infections, London, UK
    Hum Vaccin 2:68-73. 2006
  9. pmc Deaths from norovirus among the elderly, England and Wales
    John P Harris
    Centre for Infections, GEZI, Health Protection Agency, London, UK
    Emerg Infect Dis 14:1546-52. 2008
  10. pmc The cost effectiveness of opportunistic chlamydia screening in England
    Elisabeth J Adams
    Modelling and Economics Unit, Health Protection Agency, 61 Colindale Avenue, Colindale, London NW9 5EQ, UK
    Sex Transm Infect 83:267-74; discussion 274-5. 2007

Collaborators

Detail Information

Publications38

  1. ncbi request reprint The 23-valent pneumococcal polysaccharide vaccine. Part II. A cost-effectiveness analysis for invasive disease in the elderly in England and Wales
    Alessia Melegaro
    Modelling and Economics Unit, Health Protection Agency, Communicable Disease Surveillance Centre, London NW9 5EQ, UK
    Eur J Epidemiol 19:365-75. 2004
    ....
  2. doi request reprint Estimating the impact of childhood influenza vaccination programmes in England and Wales
    Emilia Vynnycky
    Modelling and Economics Unit, Health Protection Agency Centre for Infections, 61 Colindale Avenue, Colindale, London NW9 5HT, UK
    Vaccine 26:5321-30. 2008
    ..Consistently high levels of vaccination coverage among pre-school children has the potential to bring benefits to both those vaccinated and the community...
  3. pmc The average cost of measles cases and adverse events following vaccination in industrialised countries
    HELENE CARABIN
    Department of Infectious Disease Epidemiology, Imperial College Faculty of Medicine, London, UK
    BMC Public Health 2:22. 2002
    ..The objective of this study is to develop a model to estimate the average cost per measles case and per adverse event following measles immunisation using the Netherlands (NL), the United Kingdom (UK) and Canada as examples...
  4. ncbi request reprint The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales
    W J Edmunds
    Department of Economics, City University, Northampton Square, EC1 0HB, London, UK
    Vaccine 19:3076-90. 2001
    ....
  5. ncbi request reprint The effect of vaccination on the epidemiology of varicella zoster virus
    W J Edmunds
    Immunisation Division, Colindale, London NW9 5EQ, UK
    J Infect 44:211-9. 2002
    ..Meanwhile sensitive surveillance of both chickenpox and shingles is essential in countries that have implemented, or are about to implement, varicella vaccination...
  6. ncbi request reprint The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales
    W John Edmunds
    Immunisation Division, PHLS Communicable Disease Surveillance Centre, 61 Collindale Avenue, NW9 5EQ, London, UK
    Vaccine 20:1316-30. 2002
    ..Significant uncertainty remains regarding the epidemiology of pertussis and the impact of booster doses. Nevertheless, the introduction of acellular boosters, particularly at 4 years, has the potential to be cost-effective in the UK...
  7. ncbi request reprint Measles vaccination in Africa: by how much could routine coverage be improved?
    W J Edmunds
    PHLS Communicable Disease Surveillance Centre, NW9 5EQ, London, UK
    Vaccine 20:16-8. 2001
    ..This difference amounts to 3 million African children who will not be vaccinated against measles this year even though they probably have access to immunisation services...
  8. ncbi request reprint Modeling future changes to the meningococcal serogroup C conjugate (MCC) vaccine program in England and Wales
    Caroline L Trotter
    Immunisation Department, Health Protection Agency Centre for Infections, London, UK
    Hum Vaccin 2:68-73. 2006
    ..The inclusion of a booster dose is likely to improve the impact of the MCC program and reducing the number of doses in infancy will improve cost-effectiveness and create space in the schedule for the addition of other vaccines...
  9. pmc Deaths from norovirus among the elderly, England and Wales
    John P Harris
    Centre for Infections, GEZI, Health Protection Agency, London, UK
    Emerg Infect Dis 14:1546-52. 2008
    ..5%-18.5%) of deaths caused by noninfectious intestinal disease were associated with norovirus. An estimated 80 deaths each year in this age group may be associated with norovirus infection...
  10. pmc The cost effectiveness of opportunistic chlamydia screening in England
    Elisabeth J Adams
    Modelling and Economics Unit, Health Protection Agency, 61 Colindale Avenue, Colindale, London NW9 5EQ, UK
    Sex Transm Infect 83:267-74; discussion 274-5. 2007
    ..This study aims to estimate the cost effectiveness of (a) the NCSP strategy (annual screening offer to men and women aged under 25 years) and (b) alternative screening strategies...
  11. pmc Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison
    Andrew J Sutton
    Health Protection Agency, Centre for Infections, 61 Colindale Ave, London NW9 5EQ, UK
    BMC Public Health 6:170. 2006
    ..The aim of this work is to examine the cost effectiveness of a number of alternative HCV case-finding strategies on prison reception..
  12. ncbi request reprint Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model
    Caroline L Trotter
    Modelling and Economics Unit, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London, NW95EQ, UK
    Med Decis Making 26:38-47. 2006
    ..The latter effect was not accounted for in the previous economic analysis of the MCC program...
  13. doi request reprint Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England
    Albert Jan van Hoek
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, London NW9 5EQ, UK
    Vaccine 29:2411-20. 2011
    ..At high coverage (90% and 80% coverage) this is unlikely to be the case. These results will be used to inform a cost-effectiveness analysis of combined varicella and zoster vaccination programmes...
  14. doi request reprint Economic evaluation of infant and adolescent hepatitis B vaccination in the UK
    M Ruby Siddiqui
    Health Protection Agency, Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
    Vaccine 29:466-75. 2011
    ....
  15. pmc Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic
    M Ruby Siddiqui
    Health Protection Agency, London, UK
    Emerg Infect Dis 14:267-74. 2008
    ..Stockpiling sufficient AV drugs (but not near-patient tests) to treat all patients with clinical cases would be cost-effective, provided AV drugs are effective at preventing deaths from pandemic influenza...
  16. ncbi request reprint Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy
    Susan Hahne
    Health Protection Agency, Communicable Disease Surveillance Centre, Colindale, 61 Colindale Avenue, London NW9 5EQ, UK
    J Clin Virol 29:211-20. 2004
    ..The incidence of hepatitis B virus (HBV) infection in the UK is low. Since the infection can have serious sequelae, there is a continuing need to examine its epidemiology so as to inform control measures...
  17. pmc A metapopulation modelling framework for gonorrhoea and other sexually transmitted infections in heterosexual populations
    Mark I Chen
    Health Protection Agency, Centre for Infections, London NW9 5EQ, UK
    J R Soc Interface 6:775-91. 2009
    ..Finally, we extend the model to explain the distribution of other STIs, using chlamydia as an example of a more ubiquitous bacterial STI...
  18. doi request reprint Different transmission patterns in the early stages of the influenza A(H1N1)v pandemic: a comparative analysis of 12 European countries
    Stefan Flasche
    Centre for Infections, Health Protection Agency, London, UK
    Epidemics 3:125-33. 2011
    ..However, much uncertainty remains. With better information on the role of these epidemiological factors, the control of influenza could be improved...
  19. pmc Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales
    Caroline L Trotter
    Immunisation Division, PHLS Communicable Disease Surveillance Centre, London NW9 5EQ
    BMJ 324:809. 2002
    ..To assess the cost effectiveness of a meningococcal serogroup C conjugate vaccination campaign in 0-17 year olds...
  20. ncbi request reprint Sero-epidemiological patterns of Epstein-Barr and herpes simplex (HSV-1 and HSV-2) viruses in England and Wales
    Marianne C Morris
    Immunisation Division, Communicable Disease Surveillance Centre, London, United Kingdom
    J Med Virol 67:522-7. 2002
    ..Continuing surveillance of these herpes viruses is necessary as the predicted changes could have a significant public health impact, especially in the young adult population...
  21. pmc Using an online survey of healthcare-seeking behaviour to estimate the magnitude and severity of the 2009 H1N1v influenza epidemic in England
    Ellen Brooks-Pollock
    Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK
    BMC Infect Dis 11:68. 2011
    ....
  22. pmc Epidemiology and cost of nosocomial gastroenteritis, Avon, England, 2002-2003
    Ben A Lopman
    Health Protection Agency, London, UK
    Emerg Infect Dis 10:1827-34. 2004
    ..Outbreaks were contained faster (7.9 vs. 15.4 days, p = 0.0023) when units were rapidly closed to new admissions (<4 days). Implementing control measures rapidly may be effective in controlling outbreaks...
  23. ncbi request reprint Estimating the number of deaths with rotavirus as a cause in England and wales
    Mark Jit
    Modelling and Economics Unit, Immunisation Department, Health Protection Agency, London, UK
    Hum Vaccin 3:23-6. 2007
    ..The two methods gave estimates of 3.8 and 3.2 rotavirus deaths a year respectively...
  24. doi request reprint The possible macroeconomic impact on the UK of an influenza pandemic
    Marcus R Keogh-Brown
    Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK
    Health Econ 19:1345-60. 2010
    ..5/2.5%, compared with our severe scenario reductions of 29.5/6%. These results clearly indicate the significance of behavioural change over disease parameters...
  25. ncbi request reprint The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses
    Alessia Melegaro
    Modelling and Economics Unit, HPA Communicable Disease Surveillance Centre, London, UK
    Eur J Epidemiol 19:353-63. 2004
    ..The vaccine has little or no effect against pneumonia (VE = 16% in the general elderly and -20% in HRG)...
  26. pmc Developing a realistic sexual network model of chlamydia transmission in Britain
    Katherine M E Turner
    Health Protection Agency, Centre for Infections, 61 Colindale Ave, Colindale, London, NW9 5EQ, UK
    Theor Biol Med Model 3:3. 2006
    ..Mathematical models provide a theoretical framework for understanding the key epidemiological features of chlamydia: sexual behaviour, health care seeking and transmission dynamics...
  27. pmc Deaths from chickenpox. Deaths from chickenpox in adults are decreasing
    Marc Brisson
    BMJ 324:609. 2002
  28. ncbi request reprint Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis
    Philippe Beutels
    Viral Hepatitis Prevention Board, Antwerp, Belgium
    Pharmacoeconomics 20:1-7. 2002
    ..While targeted hepatitis A vaccination seems economically unattractive, universal hepatitis A vaccination strategies have not yet been sufficiently investigated to draw general conclusions...
  29. ncbi request reprint Varicella vaccine and shingles
    Marc Brisson
    JAMA 287:2211; author reply 2211-2. 2002
  30. pmc Economic evaluation of human papillomavirus vaccination in the United Kingdom
    Mark Jit
    Modelling and Economics Unit, Centre for Infections, Health Protection Agency, London NW9 6BT
    BMJ 337:a769. 2008
    ..To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls against human papillomavirus infection in the United Kingdom...
  31. ncbi request reprint Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination
    Caroline L Trotter
    Modelling and Economics Unit, Centre for Infections, Health Protection Agency, London, United Kingdom
    Am J Epidemiol 162:89-100. 2005
    ..This model can be used to help predict the potential impact of vaccine strategies both in the United Kingdom and elsewhere...
  32. ncbi request reprint The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine
    Robert Welte
    Institute of Health Economics and Health Care Management, GSF National Research Center for Environment and Health, Neuherberg, Germany
    Pharmacoeconomics 23:855-74. 2005
    ..In order to improve the international comparability of such studies, firmer national and international modelling guidelines and better adherence to such guidelines seem necessary...
  33. doi request reprint Using time-use data to parameterize models for the spread of close-contact infectious diseases
    Emilio Zagheni
    Department of Demography, University of California, Berkeley, 2232 Piedmont Avenue, Berkeley, CA 94720 2120, USA
    Am J Epidemiol 168:1082-90. 2008
    ..The availability of time-use data for a large number of countries and their potential to supplement contact surveys make the methods developed extremely valuable and suitable for implementation in several different contexts...
  34. ncbi request reprint Future savings from measles eradication in industrialized countries
    HELENE CARABIN
    Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA
    J Infect Dis 187:S29-35. 2003
    ..These savings are less than previously estimated for the United States, partly because of the assumption that measles vaccines will continue to be delivered in response to possible bioterrorism threats...
  35. ncbi request reprint The cost-effectiveness of syndromic management in pharmacies in Lima, Peru
    Elisabeth J Adams
    Modelling and Economics Unit, Health Protection Agency, Communicable Disease Surveillance Center, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
    Sex Transm Dis 30:379-87. 2003
    ..Many people with sexually transmitted diseases (STDs) in Lima, Peru, seek treatment in pharmacies...
  36. ncbi request reprint Cost-effectiveness analyses of human papillomavirus vaccination
    Anthony T Newall
    School of Public Health, Faculty of Medicine, University of Sydney, Sydney, NSW, Australia
    Lancet Infect Dis 7:289-96. 2007
    ..Further refinements to model design and epidemiological variables of (type-specific) HPV disease progression, and expansions on the options for vaccine use, are required for policy making...
  37. pmc Delaying the international spread of pandemic influenza
    Ben S Cooper
    Statistics, Modelling, and Bioinformatics Department, Centre for Infections, Health Protection Agency, London, United Kingdom
    PLoS Med 3:e212. 2006
    ..Moreover, the large increases that have occurred in international air travel might be expected to lead to more rapid global dissemination than in previous pandemics...
  38. ncbi request reprint The burden of Herpes Zoster: a prospective population based study
    Fiona T Scott
    Skin Virus Laboratory, Institute for Cell and Molecular Science, 25 29 Ashfield Street, E1 1BB, UK
    Vaccine 24:1308-14. 2006
    ..PHN occurred in 13.4% of patients. The average overall cost of HZ in the first 6 months was calculated at pound524 per patient. Medical costs were highest in those aged over 65 and societal costs highest in those aged under 65 years...